1. Having immune thrombocytopenic purpura (ITP) means that your blood doesn’t clot as it should due to a low number of thrombocytes (platelets). 2. The condition is also sometimes called idiopathic or ...

Please provide your email address to receive an email when new articles are posted on . Patients with hepatitis C may be at an increased risk for developing immune thrombocytopenic purpura, according ...

Please provide your email address to receive an email when new articles are posted on . A 22-year-old white man with no prior medical problems presented to the emergency department with profuse nose ...

Immune thrombocytopenic purpura (ITP) is characterized by reduced platelet count secondary to immune-mediated destruction, this results in an increased bleeding risk. Autoantibodies binding to ...

People hospitalized with certain rare blood cell disorders frequently receive a treatment that is associated with a two- to fivefold increase in death, according to a new study that reviewed hospital ...

X. Long Zheng, MD, PhD, gives an overview on acquired thrombotic thrombocytopenic purpura including prevalence and the typical patient presentation. X. Long Zheng, MD, PhD: What is acquired TTP? TTP ...

Immune thrombocytopenic purpura (ITP) is an autoimmune disorder in which there’s both a decrease in platelet production and increased platelet destruction. Diagnosed in 1 in 10,000 people each year, ...

Immune thrombocytopenic purpura (ITP) in adults is usually a chronic disease in which a low platelet count often causes mucocutaneous bleeding. ITP is a diagnosis of exclusion. Pseudothrombocytopenia ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...